Literature DB >> 33859203

Publisher Correction: A single-dose mRNA vaccine provides a long-term protection for hACE2 transgenic mice from SARS-CoV-2.

Qingrui Huang1, Kai Ji1,2, Siyu Tian1,2, Fengze Wang1,2, Baoying Huang3, Zhou Tong4,5, Shuguang Tan4, Junfeng Hao6, Qihui Wang1,4, Wenjie Tan7, George F Gao8,9,10, Jinghua Yan11,12,13.   

Abstract

Entities:  

Year:  2021        PMID： 33859203     DOI： 10.1038/s41467-021-22820-x

Source DB:  PubMed          Journal:  Nat Commun        ISSN： 2041-1723            Impact factor:   14.919


× No keyword cloud information.
  2 in total

Review 1.  mRNA vaccines: Past, present, future.

Authors:  Mia Karam; Georges Daoud
Journal:  Asian J Pharm Sci       Date:  2022-06-30       Impact factor: 9.273

Review 2.  Advanced Materials for SARS-CoV-2 Vaccines.

Authors:  Moustafa T Mabrouk; Wei-Chiao Huang; Luis Martinez-Sobrido; Jonathan F Lovell
Journal:  Adv Mater       Date:  2022-02-07       Impact factor: 32.086
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.